Bobby Riehle

Bobby Riehle has a diverse work experience spanning multiple industries. Bobby began their career as a Research & Development Intern at Whirlpool Corporation in 2006. From there, they moved on to Chelsea Therapeutics where they worked in Drug Development from 2007 to 2008. Riehle then joined Treacy & Company as a Senior Associate from 2013 to 2016. Bobby later worked at Northeastern University as an IGERT Nanomedicine Fellow from 2010 to 2012.

In 2016, Riehle joined Trinity Partners as a Consultant and was promoted to Senior Consultant in 2017. Bobby subsequently became an Engagement Manager in 2018 before leaving in 2019. Riehle then transitioned to Fulcrum Therapeutics, where they held various positions including Director of Corporate Strategy & New Product Planning from 2019 to 2020, Senior Director of Corporate Strategy & New Product Planning from 2020 to 2021, and Executive Director and Head of Strategy & NPP from 2021 to 2021. Currently, Riehle is the Vice President and Head of Strategy at Fulcrum Therapeutics since 2021.

Bobby Riehle received a PhD in Pharmaceutics and Drug Delivery from Northeastern University in 2013. Bobby also obtained a Certificate in Business Administration from the same institution in 2012. Prior to that, they completed a Bachelor's degree in Polymer & Color Chemistry (ACS Certified) from North Carolina State University between 2003 and 2007.